Compare RAPP & KELYB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RAPP | KELYB |
|---|---|---|
| Founded | 2022 | 1946 |
| Country | United States | United States |
| Employees | N/A | 5570 |
| Industry | | Professional Services |
| Sector | | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 513.9M |
| IPO Year | 2024 | N/A |
| Metric | RAPP | KELYB |
|---|---|---|
| Price | $28.88 | $13.00 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $48.50 | N/A |
| AVG Volume (30 Days) | ★ 280.5K | 7.4K |
| Earning Date | 03-10-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 2.27% |
| EPS Growth | ★ 24.34 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $0.72 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.73 | $8.38 |
| 52 Week High | $42.27 | $125.00 |
| Indicator | RAPP | KELYB |
|---|---|---|
| Relative Strength Index (RSI) | 52.76 | 44.80 |
| Support Level | $26.67 | $12.01 |
| Resistance Level | $29.51 | $15.10 |
| Average True Range (ATR) | 1.81 | 0.62 |
| MACD | -0.08 | -0.14 |
| Stochastic Oscillator | 51.64 | 21.59 |
Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.
Kelly Services Inc is a provider of workforce solutions and consulting, and staffing services to a diverse group of clients operating in the Americas, Europe, and the Asia-Pacific region across various industries. The company's reportable segments are: Enterprise Talent Management, Science, Engineering and Technology, and Education. Maximum revenue is generated from its Enterprise Talent Management segment, which delivers temporary staffing, outcome-based, and permanent placement services focused on light industrial, contact center, and office and clerical specialties in North America across various industries. It also provides talent supply chain and workforce talent solutions, including MSP, RPO, and PPO solutions to its clients. Geographically, it derives key revenue from the USA.